• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients.

作者信息

Porcelijn Leendert, Schmidt David E, van der Schoot C Ellen, Vidarsson Gestur, de Haas Masja, Kapur Rick

机构信息

Department of Immunohematology Diagnostics, Sanquin Diagnostic Services, Amsterdam.

Sanquin Research, Department of Experimental Immunohematology and Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam.

出版信息

Haematologica. 2020 Apr;105(4):e172-e174. doi: 10.3324/haematol.2019.228908. Epub 2019 Jul 11.

DOI:10.3324/haematol.2019.228908
PMID:31296573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7109722/
Abstract
摘要

相似文献

1
Anti-glycoprotein Ibα autoantibodies do not impair circulating thrombopoietin levels in immune thrombocytopenia patients.抗糖蛋白Ibα自身抗体不会损害免疫性血小板减少症患者的循环血小板生成素水平。
Haematologica. 2020 Apr;105(4):e172-e174. doi: 10.3324/haematol.2019.228908. Epub 2019 Jul 11.
2
Acquired amegakaryocytic thrombocytopenia previously diagnosed as idiopathic thrombocytopenic purpura in a patient with hepatitis C virus infection.丙型肝炎病毒感染患者既往诊断为特发性血小板减少性紫癜，现出现获得性巨核细胞血小板减少症。
World J Gastroenterol. 2017 Sep 21;23(35):6540-6545. doi: 10.3748/wjg.v23.i35.6540.
3
Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia.免疫性血小板减少症患者的血小板生成素自身抗体和血小板生成素受体。
Br J Haematol. 2018 Apr;181(2):234-241. doi: 10.1111/bjh.15165. Epub 2018 Mar 13.
4
Suspects in the tale of lupus-associated thrombocytopenia.狼疮相关血小板减少症事件中的可疑因素。
Clin Exp Immunol. 2006 Jul;145(1):71-80. doi: 10.1111/j.1365-2249.2006.03122.x.
5
The diagnostic value of thrombopoietin level measurements in thrombocytopenia.血小板生成素水平检测在血小板减少症中的诊断价值。
Thromb Haemost. 1998 Jun;79(6):1101-5.
6
Detection of anti-GPIbα autoantibodies in a case of immune thrombocytopenia following COVID-19 vaccination.1例新冠病毒疫苗接种后免疫性血小板减少症患者中抗糖蛋白Ibα自身抗体的检测
Thromb Res. 2022 Jan;209:80-83. doi: 10.1016/j.thromres.2021.11.030. Epub 2021 Dec 7.
7
[Recent progress in immune thrombocytopenia pathophysiology and treatment].[免疫性血小板减少症的病理生理学与治疗的最新进展]
Rinsho Ketsueki. 2023;64(9):1106-1115. doi: 10.11406/rinketsu.64.1106.
8
Autoimmune-mediated thrombocytopenia after allogeneic hematopoietic stem cell transplantation: significance of detecting reticulated platelets and glycoprotein-specific platelet autoantibodies.同种异体造血干细胞移植后自身免疫性血小板减少症：检测网织血小板和糖蛋白特异性血小板自身抗体的意义。
Int J Hematol. 2022 Mar;115(3):322-328. doi: 10.1007/s12185-021-03272-x. Epub 2022 Jan 17.
9
Diagnosis and management of immune thrombocytopenia in the era of thrombopoietin mimetics.在血小板生成素模拟物时代的免疫性血小板减少症的诊断与治疗。
Hematology Am Soc Hematol Educ Program. 2011;2011:384-90. doi: 10.1182/asheducation-2011.1.384.
10
Thrombopoietin receptor agonists in conjunction with oseltamivir for immune thrombocytopenia.
AIDS. 2016 Apr 24;30(7):1141-2. doi: 10.1097/QAD.0000000000001036.

引用本文的文献

1
The effects of complement-independent, autoantibody-induced apoptosis of platelets in immune thrombocytopenia (ITP).免疫性血小板减少症（ITP）中补体非依赖性、自身抗体诱导的血小板凋亡的影响。
Ann Hematol. 2024 Dec;103(12):5157-5168. doi: 10.1007/s00277-024-05999-z. Epub 2024 Sep 14.
2
Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients.临床疑似疫苗诱导的血小板减少性血栓形成（VITT）患者中抗血小板糖蛋白抗体
Antibodies (Basel). 2024 May 1;13(2):35. doi: 10.3390/antib13020035.
3
Reference guide for the diagnosis of adult primary immune thrombocytopenia, 2023 edition.成人原发性免疫性血小板减少症诊断参考指南，2023 年版。
Int J Hematol. 2024 Jan;119(1):1-13. doi: 10.1007/s12185-023-03672-1. Epub 2023 Nov 13.
4
The interplay between GPIb/IX antibodies, platelet hepatic sequestration, and TPO levels in patients with chronic ITP.慢性 ITP 患者中 GPIb/IX 抗体、血小板肝内滞留和 TPO 水平之间的相互作用。
Blood Adv. 2023 Mar 28;7(6):1066-1069. doi: 10.1182/bloodadvances.2022007751.
5
Antiplatelet antibody predicts platelet desialylation and apoptosis in immune thrombocytopenia.抗血小板抗体预测免疫性血小板减少症中血小板去唾液酸化和凋亡。
Haematologica. 2022 Sep 1;107(9):2195-2205. doi: 10.3324/haematol.2021.279751.
6
Potential Diagnostic Approaches for Prediction of Therapeutic Responses in Immune Thrombocytopenia.免疫性血小板减少症治疗反应预测的潜在诊断方法
J Clin Med. 2021 Jul 30;10(15):3403. doi: 10.3390/jcm10153403.
7
Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments.免疫性血小板减少症：发病机制与治疗的最新进展
Hemasphere. 2021 Jun 1;5(6):e574. doi: 10.1097/HS9.0000000000000574. eCollection 2021 Jun.
8
GPIbα is the driving force of hepatic thrombopoietin generation.糖蛋白Ibα是肝脏生成血小板生成素的驱动力。
Res Pract Thromb Haemost. 2021 May 3;5(4):e12506. doi: 10.1002/rth2.12506. eCollection 2021 May.
9
Crosstalk Between Platelets and Microbial Pathogens.血小板与微生物病原体的相互作用。
Front Immunol. 2020 Aug 7;11:1962. doi: 10.3389/fimmu.2020.01962. eCollection 2020.
10
A modern reassessment of glycoprotein-specific direct platelet autoantibody testing in immune thrombocytopenia.免疫性血小板减少症中糖蛋白特异性直接血小板自身抗体检测的现代重新评估
Blood Adv. 2020 Jan 14;4(1):9-18. doi: 10.1182/bloodadvances.2019000868.

本文引用的文献

1
Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia.糖蛋白 V 是免疫性血小板减少症患者的一个相关免疫靶点。
Haematologica. 2019 Jun;104(6):1237-1243. doi: 10.3324/haematol.2018.211086. Epub 2019 Mar 28.
2
Detection of platelet autoantibodies to identify immune thrombocytopenia: state of the art.血小板自身抗体检测在免疫性血小板减少症诊断中的应用：现状。
Br J Haematol. 2018 Aug;182(3):423-426. doi: 10.1111/bjh.15404. Epub 2018 May 29.
3
GPIbα is required for platelet-mediated hepatic thrombopoietin generation.GPIbα 对于血小板介导的肝生成素生成是必需的。
Blood. 2018 Aug 9;132(6):622-634. doi: 10.1182/blood-2017-12-820779. Epub 2018 May 24.
4
Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets.机械分子信号在血小板中导致 FC 非依赖性免疫性血小板减少症。
Blood. 2018 Feb 15;131(7):787-796. doi: 10.1182/blood-2017-05-784975. Epub 2017 Dec 4.
5
Pathogenesis and Therapeutic Mechanisms in  Immune Thrombocytopenia (ITP).免疫性血小板减少症（ITP）的发病机制与治疗机制
J Clin Med. 2017 Feb 9;6(2):16. doi: 10.3390/jcm6020016.
6
The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.阿什韦尔-莫雷尔受体通过JAK2-STAT3信号通路调节肝脏血小板生成素的产生。
Nat Med. 2015 Jan;21(1):47-54. doi: 10.1038/nm.3770. Epub 2014 Dec 8.
7
The molecular mechanisms that control thrombopoiesis.控制血小板生成的分子机制。
J Clin Invest. 2005 Dec;115(12):3339-47. doi: 10.1172/JCI26674.
8
Fetal and neonatal thrombopoietin levels in alloimmune thrombocytopenia.同种免疫性血小板减少症中的胎儿及新生儿血小板生成素水平
Pediatr Res. 2002 Jul;52(1):105-8. doi: 10.1203/00006450-200207000-00019.
9
Analysis of the kinetics of TPO uptake during platelet transfusion.血小板输注过程中血小板生成素摄取动力学分析。
Transfusion. 2001 Apr;41(4):517-21. doi: 10.1046/j.1537-2995.2001.41040517.x.
10
Thrombopoietin.血小板生成素
N Engl J Med. 1998 Sep 10;339(11):746-54. doi: 10.1056/NEJM199809103391107.